These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 19338380

  • 1. Risk management and outcomes of adverse events to pioglitazone in primary care in the UK: an observational study.
    Fogg C, Kasliwal R, Shakir SA.
    Drug Saf; 2009; 32(3):229-37. PubMed ID: 19338380
    [Abstract] [Full Text] [Related]

  • 2. Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England.
    Kasliwal R, Wilton LV, Shakir SA.
    Drug Saf; 2008; 31(10):839-50. PubMed ID: 18759508
    [Abstract] [Full Text] [Related]

  • 3. Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide.
    Vlckova V, Cornelius V, Kasliwal R, Wilton L, Shakir SA.
    Drug Saf; 2009; 32(5):409-18. PubMed ID: 19419235
    [Abstract] [Full Text] [Related]

  • 4. The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database.
    Ziyadeh N, McAfee AT, Koro C, Landon J, Arnold Chan K.
    Clin Ther; 2009 Nov; 31(11):2665-77. PubMed ID: 20110009
    [Abstract] [Full Text] [Related]

  • 5. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD, Parlan G, Bailey AL, Yee G, Yu M, Chan JY.
    Clin Ther; 2009 Jan; 31(1):74-88. PubMed ID: 19243708
    [Abstract] [Full Text] [Related]

  • 6. Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.
    Lu CJ, Sun Y, Muo CH, Chen RC, Chen PC, Hsu CY.
    Cerebrovasc Dis; 2013 Jan; 36(2):145-51. PubMed ID: 24029780
    [Abstract] [Full Text] [Related]

  • 7. Case series of liver failure associated with rosiglitazone and pioglitazone.
    Floyd JS, Barbehenn E, Lurie P, Wolfe SM.
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1238-43. PubMed ID: 19623674
    [Abstract] [Full Text] [Related]

  • 8. Hypoglycaemia with pioglitazone: analysis of data from the Prescription-Event Monitoring study.
    Vlckova V, Cornelius V, Kasliwal R, Wilton L, Shakir S.
    J Eval Clin Pract; 2010 Dec; 16(6):1124-8. PubMed ID: 21176002
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database.
    Motola D, Piccinni C, Biagi C, Raschi E, Marra A, Marchesini G, Poluzzi E.
    Drug Saf; 2012 Apr 01; 35(4):315-23. PubMed ID: 22376166
    [Abstract] [Full Text] [Related]

  • 11. Long-term safety of pioglitazone versus glyburide in patients with recently diagnosed type 2 diabetes mellitus.
    Jain R, Osei K, Kupfer S, Perez AT, Zhang J.
    Pharmacotherapy; 2006 Oct 01; 26(10):1388-95. PubMed ID: 16999648
    [Abstract] [Full Text] [Related]

  • 12. Antidiabetic prescribing trends and predictors of thiazolidinedione discontinuation following the 2007 rosiglitazone safety alert.
    Hurren KM, Taylor TN, Jaber LA.
    Diabetes Res Clin Pract; 2011 Jul 01; 93(1):49-55. PubMed ID: 21440324
    [Abstract] [Full Text] [Related]

  • 13. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
    Rajagopalan R, Rosenson RS, Fernandes AW, Khan M, Murray FT.
    Clin Ther; 2004 Sep 01; 26(9):1400-10. PubMed ID: 15531002
    [Abstract] [Full Text] [Related]

  • 14. Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan.
    Hsiao FY, Huang WF, Wen YW, Chen PF, Kuo KN, Tsai YW.
    Drug Saf; 2009 Sep 01; 32(8):675-90. PubMed ID: 19591532
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U, Pop-Busui R, Eagle KA.
    Ann Pharmacother; 2008 Oct 01; 42(10):1466-74. PubMed ID: 18698014
    [Abstract] [Full Text] [Related]

  • 17. Adding pioglitazone to insulin containing regimens in type 2 diabetes: systematic review and meta-analysis.
    Clar C, Royle P, Waugh N.
    PLoS One; 2009 Jul 01; 4(7):e6112. PubMed ID: 19568428
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.